Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2002 3
2003 1
2004 2
2005 8
2006 5
2007 3
2008 3
2009 9
2010 7
2011 3
2012 7
2013 7
2014 7
2015 6
2016 10
2017 6
2018 2
2019 2
2020 4
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 16080473

87 results
Results by year
Filters applied: . Clear all
Page 1
Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: an economic evaluation of the PALM Trial.
Perrier L, Lefranc A, Pérol D, Quittet P, Schmidt-Tanguy A, Siani C, de Peretti C, Favier B, Biron P, Moreau P, Bay JO, Lissandre S, Jardin F, Espinouse D, Sebban C. Perrier L, et al. Appl Health Econ Health Policy. 2013 Apr;11(2):129-38. doi: 10.1007/s40258-013-0011-7. Appl Health Econ Health Policy. 2013. PMID: 23435861 Clinical Trial.
Pegfilgrastim and daily granulocyte colony-stimulating factor: patterns of use and neutropenia-related outcomes in cancer patients in Spain--results of the LEARN Study.
Almenar D, Mayans J, Juan O, Bueno JM, Lopez JI, Frau A, Guinot M, Cerezuela P, Buscalla EG, Gasquet JA, Sanchez J. Almenar D, et al. Eur J Cancer Care (Engl). 2009 May;18(3):280-6. doi: 10.1111/j.1365-2354.2008.00959.x. Epub 2008 Dec 8. Eur J Cancer Care (Engl). 2009. PMID: 19076208 Free PMC article.
87 results